Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Fezolinetant reduces menopause-related vasomotor symptoms
18 Aug 2023
bởiStephen Padilla
Treatment with fezolinetant 30 and 45 mg daily provides relief from moderate-to-severe vasomotor symptoms (VSM) associated with menopause, suggests a study.
Fezolinetant reduces menopause-related vasomotor symptoms
18 Aug 2023
Long-term hydrochlorothiazide use ups risk of skin cancer
17 Aug 2023
Using hydrochlorothiazide (HCTZ) for longer durations and in higher cumulative doses increases the risks for keratinocyte carcinoma and melanoma, reveals a study.
Long-term hydrochlorothiazide use ups risk of skin cancer
17 Aug 2023
Demedicalized delivery of PrEP possible, improves access
16 Aug 2023
bởiStephen Padilla
A peer-led demedicalized delivery of same-day HIV pre-exposure prophylaxis (PrEP) in various community centres is feasible, suggests a Philippines study presented at the recent IAS 2023.